StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BGIN$2.88-0.65%
Fair $2.88+0.0%

BGIN

Bgin Blockchain Limited

Technology / Computer HardwareNasdaqGM

$2.88

-0.02 (-0.65%)

Fairly Valued+0.0%Fair Value $2.88Fund rank 28/100 · Data gapFallback financials|
SA 30/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-171.1M · quality 58.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

30/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -3.2%, below the 5% threshold
Thesis & Journal · BGINLocal privado en este navegador · Bgin Blockchain Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$326M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-324.6%

↓

Gross Margin

-112.2%

↓

Debt/Equity

0.00

↓
52-Week Range$3
$2$7

TradingView lightweight chart

BGIN price, volumen y niveles de valoración

Último $2.881Periodo -41.9%
Fair value: $2.881

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+64.8%

FCF CAGR

—

FCF margin

-253.8%

FCF / Net income

0.97x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $67.4M · net income $-176.9M · FCF $-171.1M

2022-FY → 2025-FY

Gross margin

-112.2%-171.5% pts

Operating margin

-163.3%-162.2% pts

Net margin

-262.4%-261.0% pts

FCF margin

-253.8%-134.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$67.4M$67.4M$302.3M$257.3M$15.1M
Net Income$-176.9M$-176.9M$65.9M$139.7M$-220385.00
EBITDA$-89.0M$-89.0M$113.1M$176.3M$1.6M
EPS——0.581.22-0.00
Gross Margin-112.2%-112.2%42.2%77.4%59.3%
Operating Margin-163.3%-163.3%34.2%67.4%-1.1%
Net Margin-262.4%-262.4%21.8%54.3%-1.5%
Balance Sheet
Debt/Equity0.000.000.000.00—
Current Ratio1.681.68———
Cash Flow
Free Cash Flow$-171.1M$-171.1M$-212.3M$-38.0M$-17.9M
Returns
ROE-324.6%-324.6%31.4%93.9%-2.4%
Valuation
P/B5.985.98———
Growth & Yield
Revenue Growth-77.7%-77.7%17.5%1609.0%—
EPS Growth——-52.4%63489.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total -41.9%

Total return

-41.9%

Start / end P/E

n/dx → n/dx

EPS bridge

0.58 → n/d

Residual

-41.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-41.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.